Evidence map›Paper›PMID 36353677›Full record

ReviewInnovation (Cambridge (Mass.))2022

Single-cell technologies: From research to application.

Lu Wen, Guoqiang Li, Tao Huang, Wei Geng, Hao Pei, Jialiang Yang, Miao Zhu, Pengfei Zhang, Rui Hou, Geng Tian and 14 more

Abstract readReview
In one paragraph

Review in Innovation (Cambridge (Mass.)), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Lu WenBiomedical Pioneering Innovation Centre (BIOPIC), Peking University, Beijing 100871, China.
Guoqiang LiBiomedical Pioneering Innovation Centre (BIOPIC), Peking University, Beijing 100871, China.
Tao HuangBio-Med Big Data Center, CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China.
Wei GengSchool of Chemical Engineering and Technology, Sun Yat-Sen University, Zhuhai 519082, China.
Hao PeiMozhuo Biotech (Zhejiang) Co., Ltd., Tongxiang, Jiaxing 314500, China.
Jialiang YangGeneis (Beijing) Co., Ltd., Beijing 100102, China.
Miao ZhuGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.
Pengfei ZhangDepartment of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Rui HouGeneis (Beijing) Co., Ltd., Beijing 100102, China.
Geng TianGeneis (Beijing) Co., Ltd., Beijing 100102, China.
Wentao SuSchool of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China.
Jian ChenState Key Laboratory of Transducer Technology, Aerospace Information Research Institute, Chinese Academy of Sciences, Beijing 100190, China.
Dake ZhangKey Laboratory of Biomechanics and Mechanobiology, Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Engineering Medicine, Beihang University, Beijing 100083, China.
Pingan ZhuDepartment of Mechanical Engineering, City University of Hong Kong, Hong Kong 999077, China.
Wei ZhangChongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing 400714, China.
Xiuxin ZhangCenter of Peony, Institute of Vegetables and Flowers, Chinese Academy of Agricultural Sciences, Key Laboratory of Biology and Genetic Improvement of Flower Crops (North China), Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture and Rural Affairs, Beijing 100081, China.
Ning ZhangDepartment of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Yunlong ZhaoAdvanced Technology Institute, University of Surrey, Guildford, Surrey, GU2 7XH, UK.
Xin CaoInstitute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Guangdun PengGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.
Xianwen RenBiomedical Pioneering Innovation Centre (BIOPIC), Peking University, Beijing 100871, China.
Nan JiangWest China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu 610041, China.
Caihuan TianCenter of Peony, Institute of Vegetables and Flowers, Chinese Academy of Agricultural Sciences, Key Laboratory of Biology and Genetic Improvement of Flower Crops (North China), Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture and Rural Affairs, Beijing 100081, China.
Zi-Jiang ChenCenter for Reproductive Medicine, Shandong University, Jinan, Shandong, 250012, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, more and more single-cell technologies have been developed. A vast amount of single-cell omics data has been generated by large projects, such as the Human Cell Atlas, the Mouse Cell Atlas, the Mouse RNA Atlas, the Mouse ATAC Atlas, and the Plant Cell Atlas. Based on these single-cell big data, thousands of bioinformatics algorithms for quality control, clustering, cell-type annotation, developmental inference, cell-cell transition, cell-cell interaction, and spatial analysis are developed. With powerful experimental single-cell technology and state-of-the-art big data analysis methods based on artificial intelligence, the molecular landscape at the single-cell level can be revealed. With spatial transcriptomics and single-cell multi-omics, even the spatial dynamic multi-level regulatory mechanisms can be deciphered. Such single-cell technologies have many successful applications in oncology, assisted reproduction, embryonic development, and plant breeding. We not only review the experimental and bioinformatics methods for single-cell research, but also discuss their applications in various fields and forecast the future directions for single-cell technologies. We believe that spatial transcriptomics and single-cell multi-omics will become the next booming business for mechanism research and commercial industry.

Identifiers

PMID36353677
PMCPMC9637996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.